Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Ann Intern Med
    June 2024
  1. MIRONOVA M, Sherker AH
    In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
    Ann Intern Med. 2024;177:JC63.
    >> Share

    April 2024
  2. LAKE JE, Kitch DW, Kantor A, Muthupillai R, et al
    The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354.
    >> Share

  3. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
    Gastroenterology/Hepatology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
    >> Share

    June 2023
  4. LEE BP, Dodge JL, Mack WJ, Leventhal AM, et al
    National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018.
    Ann Intern Med. 2023;176:879-882.
    >> Share

    February 2023
  5. MUKHERJEE S
    In nonalcoholic fatty liver disease, a diet of freshwater fish vs. freshwater fish plus red meat reduced liver fat.
    Ann Intern Med. 2023;176:JC20.
    >> Share

    December 2022

  6. Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/P22-0022.
    >> Share

  7. HANSEN CD, Gram-Kampmann EM, Hansen JK, Hugger MB, et al
    Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
    Ann Intern Med. 2022 Dec 13. doi: 10.7326/M22-1787.
    >> Share

    July 2022
  8. CEPEDA JA, Thomas DL, Astemborski J, Rudolph JE, et al
    Impact of Hepatitis C Treatment Uptake on Cirrhosis and Mortality in Persons Who Inject Drugs : A Longitudinal, Community-Based Cohort Study.
    Ann Intern Med. 2022 Jul 12. doi: 10.7326/M21-3846.
    >> Share

  9. KORETZ RL
    Aspirin use is associated with reduced risk for hepatocellular carcinoma.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0049.
    >> Share

  10. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Portal Vein Thrombosis: What Could Be the Cause?
    Ann Intern Med. 2022;175:CG1.
    >> Share

    November 2021
  11. SEEBERG KA, Borgeraas H, Hofso D, Smastuen MC, et al
    Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/M21-1962.
    >> Share


  12. Summary for Patients: Do Gastric Bypass and Sleeve Gastrectomy Help Reduce Liver Fat Content and Scarring in Patients With Type 2 Diabetes?
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/P21-0012.
    >> Share

    September 2021
  13. TRAN AN, Lim JK
    Care of the Patient With Abnormal Liver Test Results.
    Ann Intern Med. 2021;174:ITC129-ITC144.
    >> Share

    August 2021
  14. HERCUN J, Sherker AH
    In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    >> Share

    July 2021
  15. KORETZ RL
    In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    >> Share

  16. TAPPER EB, Bosch J
    Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.
    Ann Intern Med. 2021;174:HO2-HO3.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016